- Unbeliebable: White House turns Bieber petition response into immigration screed
- Obama signs law denying Iran ambassador’s visa, but says law is ‘advisory’
- Mich. judge to laughing convicted killer: ‘I hope you die in prison’
- Man charged in Kansas City-area highway shootings
- Keystone XL pipeline still on hold after State Dept. decision
- Fla. man charged with killing 16-month-old son to play Xbox undisturbed
- Drones from the deep: Pentagon develops ocean-floor attack robots
- Michigan mayor slaps back atheists’ try to erect ‘reason station’ at city hall
- PHILLIPS: Where is the conservative establishment?
- 7.5-magnitude earthquake shakes southern Mexico
Obama administration to appeal Plan B contraception age limit
The Obama administration, under massive pressure from both sides of the culture war over contraception, has decided to appeal a federal court’s order to make a morning-after pill available to everyone without a prescription, just a day after expanding access to the pills for younger teenage girls.
On Wednesday evening, Justice Department officials said they had filed the appeal with the 2nd U.S. Circuit Court of Appeals and also asked a district court to put on hold the early April ruling by Judge Edward Korman of New York that the administration must make Plan B One-Step available without restrictions.
In filing notice with the appeals court, Justice said Judge Korman exceeded his authority in ordering that Plan B and a generic equivalent must be sold to everybody like aspirin by May 5.
“The public interest will not be served by reclassification of drugs as non-prescription by order of a court, without appropriate agency decision-making procedures being followed,” U.S. Attorney Loretta E. Lynch said in a letter to Judge Korman, noting that the government wants to “prevent public uncertainty regarding the status of the drugs at issue.”
“Moreover, if the status of these drugs is changed and later reversed, it can lead to situations in which women mistakenly believe that they can obtain the drug without a prescription or at certain locations where it used to be, but is no longer, available,” Ms. Lynch wrote. “Depending on the outcome of the appeal, the problem would be exacerbated because products with incorrect labeling will presumably remain on pharmacy shelves.”
The appeal was filed one day after the Food and Drug Administration moved to let girls as young as 15 obtain Plan B One-Step, one of the three types of emergency contraception, without a prescription. The current age limit is 17.
Ms. Lynch said the FDA did not make the change as a direct response to the federal case, but noted that all of the plaintiffs in the pending civil case were at least 15, so none of them would be injured by the decision to cut off access at that age.
The White House said Wednesday, before Justice announced its appeal, that the decision was made entirely by FDA officials.
“This is a decision that the FDA made, and that is appropriate because it’s an independent agency,” White House press secretary Jay Carney said Wednesday. “The president, the White House, did not weigh in on this decision.”
FDA officials said they were just approving a request by the drug’s manufacturer, Teva Women’s Health Inc., and that the decision had nothing to do with the New York case.
That case puts the administration on tenuous ground with both its traditional allies and nemeses in the battle over abortion.
Conservative groups say the government is usurping the role of parents, while groups such as the Planned Parenthood Federation of America and the National Organization for Women say the administration is ignoring scientific evidence that the pill is suitable for all ages.
Judge Edward Korman rebuked Health and Human Services Secretary Kathleen Sebelius for making an “obviously political” decision in 2011 — one year before Mr. Obama’s re-election — to prohibit the sale of Plan B One-Step and its generic forms to girls younger than 17 unless they had a prescription.
Mr. Carney said the president supported Mrs. Sebelius’ decision, which was based on a lack of data regarding the pill’s effects on “younger girls and teens of reproductive age.”
The spokesman drew a distinction between Tuesday’s FDA approval and the judge’s 2011 decision, which was based on “the proposition that this medication could be made available to anyone of any age.”
© Copyright 2014 The Washington Times, LLC. Click here for reprint permission.
About the Author
Tom Howell Jr. covers politics for The Washington Times. He can be reached at email@example.com.
- Sebelius not running for Senate, HHS confirms: Report
- Red fox makes a home for himself at the White House: Report
- 7.5-magnitude earthquake shakes southern Mexico
- Sen. Joe Manchin keeps his options open for 2016
- Many Americans would quickly face financial hardship after losing job, poll shows
Latest Blog Entries
TWT Video Picks
Women losing coverage under Obamacare, too
- Scalia to students on high taxes: At a certain point, 'perhaps you should revolt'
- Former Ranger breaks silence on Pat Tillman death: I may have killed him
- Special Forces' suicide rates hit record levels casualties of 'hard combat'
- Feds approve powdered alcohol; 'Palcohol' available later this year
- EDITORIAL: Mark Warner running scared?
- Army goes to war with National Guard, seizes Apache attack helicopters
- Critics rail against liberal bias for commencement speakers
- Harry Reid blasts Bundy ranch supporters as 'domestic terrorists'
- EDITORIAL: More Lerner smoking-gun emails at IRS
- EDITORIAL: Republicans finally fight back in phony 'war on women'
Top 10 handguns in the U.S.